Industry Watch Alert
CMS has issued new guidance reinforcing patient protections in the organ donation process, prohibiting OPOs and donor hospitals from influencing life support decisions or coercing families. A strengthened oversight roadmap through 2027 includes performance reporting, recertification surveys, and a proposed Conditions for Coverage Final Rule with potential implications for payer networks, transplant access, and member care navigation.
For payer organizations, this guidance introduces no immediate coverage or reimbursement changes, but reinforces longer-term operational considerations tied to transplant network integrity, OPO service area stability, and member access continuity.
The new family decision-making protections may modestly affect organ availability timelines by design, which could shift transplant authorization volumes or episode timing for members on waiting lists. The enforcement change requiring surveyors to cite noncompliance even after correction is a meaningful accountability shift. Payers with transplant centers in their networks should monitor how those facilities perform under heightened scrutiny.
The projected OPO Conditions for Coverage Final Rule (late 2026) and subsequent recertification or decertification actions for under-performing OPOs could create service area disruptions in certain regions, with downstream effects on transplant access, member wait times, acuity at time of transplant, and episode costs.
Finally, CMS framed this guidance explicitly within the broader context of declining public trust in physicians and hospitals, down more than 40% between 2020 and 2024. Payers engaged in serious illness care navigation, end-of-life planning, or donor registration outreach should factor that trust environment into member communication strategies.
Executive Summary
CMS has issued new guidance reinforcing the responsibilities of Organ Procurement Organizations (OPOs) and donor hospitals to ensure patients receive full medical care regardless of donor status, and that families are given adequate time to make organ donation decisions free from coercion. The guidance prohibits OPOs from influencing life support withdrawal timing or death declarations, and requires that death be declared according to accepted medical standards before organ recovery begins. A key enforcement change requires surveyors to cite noncompliance even when issues are subsequently corrected. CMS has outlined a strengthened OPO oversight roadmap through 2027, including performance reporting, onsite recertification surveys, a proposed Conditions for Coverage Final Rule, and potential recertification or decertification actions for under-performing OPOs.
BHM Healthcare Solutions supports payer organizations with independent clinical review, utilization management expertise, and quality oversight to help coverage decisions remain consistent, defensible, and aligned with evolving regulatory expectations.
Previous Alerts
Sources
Centers for Medicare & Medicaid Services. (2025).
CMS Strengthens Patient Protections and Accountability in Organ Donation System.
U.S. Department of Health & Human Services.
Related resources cited in the press release:
- QSO Memo: https://www.cms.gov/medicare/health-safety-standards/quality-safety-oversight-general-information/policy-memos/policy-memos-states-cms-locations/organ-procurement-organizations-opos-donor-hospitals-responsibilities
- SOM Appendix: https://www.cms.gov/medicare/health-safety-standards/quality-safety-oversight-general-information/policy-memos/policy-memos-states-cms-locations/revisions-organ-procurement-organization-opo-interpretive-guidance-state-operations-manual-appendix
- HRSA Organ Procurement and Transplantation: https://www.hrsa.gov/optn-modernization
Each week, we email a summary along with links to our newest articles and resources. From time to time, we also send urgent news updates with important, time-sensitive details.
Please fill out the form to subscribe.
Note: We do not share our email subscriber information and you can unsubscribe at any time.
Partner with BHM Healthcare Solutions
BHM Healthcare Solutions offers expert consulting services to guide your organization through price transparency & other regulatory complexities for optimal operational efficiency. We leverage over 20 years of experience helping payers navigate evolving prior authorization requirements with efficiency, accuracy, and transparency.
Our proven processes reduce administrative errors, accelerate turnaround times, and strengthen provider relationships, while advanced reporting and analytics support compliance readiness and audit preparation. From operational improvements to strategic positioning, we partner with organizations to turn regulatory change into an opportunity for clinical and business excellence.